Biomemory’s DNA Shield stores critical data in synthetic DNA beyond the reach of cyberattacks

Biomemory has officially launched DNA Shield, a commercial storage service that utilizes synthetic DNA to protect critical digital assets. By encoding data into physical molecules, the company offers an airgapped, offline storage solution that is immune to traditional cyberattacks and power-dependent failures. Designed for "cold data"—such as cryptographic keys, intellectual property, and biometric records—the platform promises a lifespan of up to 150 years. Following the acquisition of Catalog Technologies, Biomemory is positioning this as the first "Molecular IT" product to reach the market. The service is currently in a pilot phase, with a full commercial rollout expected in 2027. Subscriptions for the service start at €10,000 per month, targeting organizations that require high-security, long-term data preservation that remains inaccessible to cloud-based threats or system-wide breaches.